MENU
PPH
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

PPH stock forecast, quote, news & analysis

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index... Show more

Category: #Health
PPH
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for PPH with price predictions
Sep 30, 2026

Aroon Indicator for PPH shows an upward move is likely

PPH's Aroon Indicator triggered a bullish signal on September 03, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 291 similar instances where the Aroon Indicator showed a similar pattern. In 240 of the 291 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 57 cases where PPH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

Following a +0.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where PPH advanced for three days, in 283 of 345 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

PPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PPH as a result. In 65 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The Moving Average Convergence Divergence Histogram (MACD) for PPH turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 37 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.

PPH moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PPH crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 57%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), McKesson Corp (NYSE:MCK), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN).

Industry description

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Market Cap

The average market capitalization across the VanEck Pharmaceutical ETF (PPH) ETF is 161.63B. The market cap for tickers in the group ranges from 2.1B to 1.06T. LLY holds the highest valuation in this group at 1.06T. The lowest valued company is PRGO at 2.1B.

High and low price notable news

The average weekly price growth across all stocks in the VanEck Pharmaceutical ETF (PPH) ETF was 3%. For the same ETF, the average monthly price growth was 9%, and the average quarterly price growth was 168%. PRGO experienced the highest price growth at 7%, while AXSM experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the VanEck Pharmaceutical ETF (PPH) ETF was 4%. For the same stocks of the ETF, the average monthly volume growth was 10% and the average quarterly volume growth was 29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 30
P/E Growth Rating: 44
Price Growth Rating: 46
SMR Rating: 59
Profit Risk Rating: 57
Seasonality Score: 6 (-100 ... +100)
View a ticker or compare two or three
PPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
335 Madison Ave.19th FloorNew York
Phone
888-658-8287
Web
www.marketvectorsetfs.com
Aroon Indicator for PPH shows an upward move is likely